First-in-human phase I study of a selective c-Met inhibitor volitinib (HMP504/AZD6094) in patients with advanced solid tumors

Hui Kong Gan; Jason Lickliter; Michael Millward; Yi Gu; Weiguo Su; Melanie Frigault; Chuan Qi; Hua Mu

doi:10.1200/jco.2014.32.15_suppl.11111

First-in-human phase I study of a selective c-Met inhibitor volitinib (HMP504/AZD6094) in patients with advanced solid tumors

Hui Kong Gan, Jason Lickliter, Michael Millward, Yi Gu, Weiguo Su, Melanie Frigault, Chuan Qi, Hua Mu

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

8 Citations (Web of Science)

Original language	English
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	32
Issue number	15
DOIs	https://doi.org/10.1200/jco.2014.32.15_suppl.11111
Publication status	Published - 20 May 2014
Externally published	Yes
Event	50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, United States Duration: 30 May 2014 → 3 Jun 2014

Access to Document

10.1200/jco.2014.32.15_suppl.11111

Cite this

@article{166739f3def9439c8a7fa4c750e55298,

title = "First-in-human phase I study of a selective c-Met inhibitor volitinib (HMP504/AZD6094) in patients with advanced solid tumors",

author = "Gan, {Hui Kong} and Jason Lickliter and Michael Millward and Yi Gu and Weiguo Su and Melanie Frigault and Chuan Qi and Hua Mu",

year = "2014",

month = may,

day = "20",

doi = "10.1200/jco.2014.32.15_suppl.11111",

language = "English",

volume = "32",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15",

note = "50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) ; Conference date: 30-05-2014 Through 03-06-2014",

}

TY - JOUR

T1 - First-in-human phase I study of a selective c-Met inhibitor volitinib (HMP504/AZD6094) in patients with advanced solid tumors

AU - Gan, Hui Kong

AU - Lickliter, Jason

AU - Millward, Michael

AU - Gu, Yi

AU - Su, Weiguo

AU - Frigault, Melanie

AU - Qi, Chuan

AU - Mu, Hua

PY - 2014/5/20

Y1 - 2014/5/20

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uwapure5-25&SrcAuth=WosAPI&KeyUT=WOS:000358613204844&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1200/jco.2014.32.15_suppl.11111

DO - 10.1200/jco.2014.32.15_suppl.11111

M3 - Abstract/Meeting Abstract

SN - 0732-183X

VL - 32

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

T2 - 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Y2 - 30 May 2014 through 3 June 2014

ER -

First-in-human phase I study of a selective c-Met inhibitor volitinib (HMP504/AZD6094) in patients with advanced solid tumors

Access to Document

Other files and links

Cite this